Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlkemy Capital. Regulatory News (ALK)

Share Price Information for Alkemy Capital. (ALK)

Share Price is delayed by 15 minutes
Get Live Data
234.00    -12.50 (-4.91%)
Bid:
236.00
Ask:
248.00
Spread: 12.00 (5.085%)
Market Cap: £25.69m
ALK Live PriceLast checked at - London Stock Exchange

Intraday Alkemy Capital. Share Chart

Loan Conversion

9 Dec 2025 11:40

RNS Number : 8585K
Alkemy Capital Investments PLC
09 December 2025
 

9 December 2025

 

Alkemy Capital Investments Plc

Loan Conversion

 

Alkemy Capital Investments Plc ("Alkemy" or the "Company") (LSE: ALK) (JV2:FRA) has received a loan conversion notice from the debt facility provider, as set out in the RNS dated 31 July 2025, pursuant to which £250,000 of principal and £513.70 of interest is being converted at £2.77, resulting in the issue of 90,572 ordinary shares of 2 pence each in the Company ("Ordinary Shares").

The Company will accordingly issue 90,572 new Ordinary Shares in the Company (the "New Ordinary Shares").

Admission

Application will be made for the New Ordinary Shares to be admitted to trading on the Equity Shares (transition) category of the Official List and the Main Market of the London Stock Exchange at 8.00 a.m. on 15 December 2025 ("Admission").

Total Voting Rights

The Company hereby notifies the market, in accordance with the FCA's Disclosure Guidance and Transparency Rules, that on Admission, the Company's enlarged share capital will consist of 10,662,592 Ordinary Shares. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Further information

 

For further information, please visit Alkemy's website: www.alkemycapital.co.uk or TVL's website www.teesvalleylithium.co.uk.

-Ends-

Alkemy Capital Investments Plc

 

Tel: 0207 317 0636

info@alkemycapital.co.uk

Zeus Capital

Tel: 0203 829 5000

 

ABOUT US

 

Alkemy Capital Investments plc: Alkemy is focused on the development of critical mineral infrastructure to support the global energy transition. Through its wholly owned subsidiary, TVL, Alkemy is leading the way in establishing Europe's first independent lithium hydroxide refinery.

 

Tees Valley Lithium Limited: TVL is committed to supplying battery-grade lithium chemicals to meet the growing demand of the electric vehicle supply chain in Europe. Strategically located at in Teesside, UK, TVL is developing a low-carbon, independent lithium supply chain for European battery manufacturers.

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEFKLFBELLXFBZ
Date   Source Headline
27th Jul 20094:42 pmRNSHolding(s) in Company
15th Jul 20097:00 amRNSOperations Update
2nd Jul 20092:11 pmRNSHolding(s) in Company
29th Jun 20095:04 pmRNSAnnual Report and Accounts
11th May 20093:40 pmRNSHolding(s) in Company
6th May 20097:00 amRNSAGM Statement
20th Mar 200912:21 pmRNSDirector/PDMR Shareholding
19th Mar 200911:31 amRNSDirector/PDMR Shareholding
18th Mar 20091:02 pmRNSHolding(s) in Company
18th Mar 20097:01 amRNSBoard Change
18th Mar 20097:00 amRNSPreliminary Results
17th Mar 200911:56 amRNSHolding(s) in Company
5th Mar 20097:00 amRNSCompletion of sale of interest in Pro 2
2nd Mar 20097:00 amRNSAgreed sale of interest in Pro 2
27th Feb 20092:44 pmRNSHolding(s) in Company
5th Nov 20081:52 pmRNSDirector/PDMR Shareholding
3rd Nov 200810:12 amRNSDirector/PDMR Shareholding
3rd Nov 200810:08 amRNSAppointment of New CEO
28th Oct 20084:25 pmRNSHolding(s) in Company
13th Oct 20085:46 pmRNSHolding(s) in Company
30th Sep 20085:25 pmRNSTotal Voting Rights
24th Sep 20083:49 pmRNSExercise of options
17th Sep 20087:00 amRNSInterim Results
27th Aug 200811:47 amRNSNotification of Results
5th Aug 20082:14 pmRNSWarning to Shareholders
22nd Jul 20082:23 pmRNSHolding(s) in Company
17th Jul 200810:25 amRNSHolding(s) in Company
14th Jul 200810:25 amRNSExercise of Options
27th Jun 20084:18 pmRNSAnnual Report and Accounts
23rd Jun 20083:23 pmRNSHolding(s) in Company
12th Jun 20082:14 pmRNSHolding(s) in Company
9th Jun 200810:53 amRNSHolding(s) in Company
28th May 20083:32 pmRNSTotal Voting Rights
8th May 20084:47 pmRNSExercise of Options
7th May 20087:01 amRNSAGM Statement
30th Apr 20083:08 pmRNSTotal Voting Rights
16th Apr 20084:47 pmRNSHolding(s) in Company
16th Apr 20083:17 pmRNSExercise of Options
4th Apr 20082:23 pmRNSHolding(s) in Company
1st Apr 20085:20 pmRNSHolding(s) in Company
26th Mar 20083:45 pmRNSHolding(s) in Company
25th Mar 20083:34 pmRNSHolding(s) in Company
19th Mar 20087:01 amRNSPreliminary Results
17th Mar 20086:24 pmRNSHolding(s) in Company
11th Mar 20087:01 amRNSTermination of talks
10th Mar 20089:33 amRNSRule 8.3- Alkane Energy
7th Mar 200811:43 amRNSRule 8.3- Alkane Energy
6th Mar 20081:48 pmRNSRule 8.3- Alkane Energy
4th Mar 200812:23 pmRNSRule 8.3- Alkane Energy
29th Feb 20082:14 pmRNSRule 8.3- Alkane Energy

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.